Research
1 in 10 U.S. adults reported GLP-1 medication use July to August 2025
The Brief
- From July to August 2025, about one in 10 U.S. adults reported taking a GLP-1 receptor agonist medication during the past year.
- The finding comes from research published in Morbidity and Mortality Weekly Report.
- The report is based on self-reported medication use.
Why it matters
The estimate gives public health researchers and clinicians a current national figure for how widely GLP-1 receptor agonist drugs are being used among US adults.
Who’s affected
- public health researchers
- clinicians and pharmacists
- health policy analysts
- #glp-1
- #obesity medication
- #public health
- #us adults
- #prescription drugs
From July to August 2025, about one in 10 U.S. adults reported taking a glucagon-like peptide-1 receptor agonist (GLP-1 RA) medication during the past year, according to research published in Morbidity and Mortality Weekly Report.